Physician profile
Joshua D Scoll
NPI 1902844681
$18,237.83
in general payments reported to CMS, 2019-2025
7 companies · $18K in 2025
The $18K reported for 2025 was more than what 99% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.28 · 2020: $15.63 · 2021: $35.26 · 2023: $54.35 · 2024: $555 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $14K · Travel and Lodging: $2,534 · Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $14,400.00 |
| Travel and Lodging | $2,534.23 |
| Food and Beverage | $1,239.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $17,718.33 | 2023-2025 | |
| Smith+Nephew, INC. | $280.82 | 2024 | Stravix, Oasis, Grafix |
| Paratek Pharmaceuticals, INC. | $139.71 | 2023-2024 | Nuzyra |
| Organogenesis INC. | $50.89 | 2020-2021 | |
| Medtronic, INC. | $18.37 | 2025 | Inceptiv |
| Stryker Corporation | $16.43 | 2025 | Lpt |
| Wright Medical Technology, INC. | $13.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Scoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.